Evergreen Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,115
Closed -$303K 1638
2026
Q1
$303K Buy
5,115
+877
+21% +$56.9K 0.01% 1113
2025
Q4
$261K Buy
4,238
+405
+11% +$24.8K 0.01% 1125
2025
Q3
$239K Buy
3,833
+522
+16% +$36.3K 0.01% 1129
2025
Q2
$264K Sell
3,311
-259
-7% -$21.7K 0.01% 863
2025
Q1
$307K Buy
3,570
+255
+8% +$20.9K 0.01% 740
2024
Q4
$259K Buy
3,315
+174
+6% +$13.5K 0.01% 816
2024
Q3
$226K Sell
3,141
-2
-0.1% -$142 0.01% 859
2024
Q2
$216K Buy
3,143
+160
+5% +$10.8K 0.01% 820
2024
Q1
$216K Buy
+2,983
New +$199K 0.01% 768

Other funds holding PBH

Evergreen Capital Management's PBH Position: Q2 2026 in Review

Evergreen Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 5,115 shares — an estimated $303K sold.

Evergreen Capital Management first reported a position in PBH in Q1 2024 and held it in 9 quarters. The position peaked at $307K in Q1 2025. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Evergreen Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Evergreen Capital Management sold 5,115 Prestige Consumer Healthcare shares in Q2 2026, an estimated $303K.
  • Evergreen Capital Management first reported a position in Prestige Consumer Healthcare in Q1 2024 and held it in 9 quarters.
  • Evergreen Capital Management's Prestige Consumer Healthcare position peaked at $307K in Q1 2025.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.